available to qualified candidates, particularly those with prior experience in laboratory management.
This recruitment is taking place at an exciting time in the Division of Hematopathology and Molecular Pathology and the Department of Pathology, which will be moving into new clinical space within the Clinical Center at St Jude. This includes new clinical laboratory space for the clinical immunopathology group. The immunopathology team has recently validated a clinical Spectral Flow Cytometry for acute leukemia diagnosis with additional assays pending for minimal residual disease and other hematopoietic abnormalities.
Qualifications
The successful candidate should have an MD degree or a combined MD/PhD degree. In addition to a record of scholarly achievements, candidates must be board-certified in AP or AP/CP, and be board-certified or eligible for board certification in Hematopathology. Experience in laboratory management is encouraged.
To apply
Applicants should submit a letter of application, academic statement, curriculum vitae, and the names of three referees directly online.
For more information
Jeffery M. Klco MD, PhD
Director, Division of Hematopathology and Molecular Pathology
Department of Pathology
St. Jude Children's Research Hospital MS #342
262 Danny Thomas Place
Memphis, TN 38105
Email: Jeffery.Klco@stjude.org
St. Jude Children's Research Hospital, founded by the late entertainer Danny Thomas, is one of the world's premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases. St. Jude is the first and only pediatric cancer center to be designated as a Comprehensive Cancer Center by the National Cancer Institute. Children from all 50 states and from around the world have come through the doors of St. Jude for treatment, and thousands more around the world have benefited from the research conducted at St. Jude - research that is shared freely with the global medical community. St. Jude is the only pediatric cancer research center where families never pay for treatments that are not covered by insurance. No child is denied treatment because of a family's inability to pay.
